Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Keros Therapeutics (KROS) Revenue: 2019-2024

Historic Revenue for Keros Therapeutics (KROS) over the last 6 years, with Dec 2024 value amounting to $3.5 million.

  • Keros Therapeutics' Revenue rose 3575.77% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.7 million, marking a year-over-year increase of 37798.31%. This contributed to the annual value of $3.5 million for FY2024, which is 2250.99% up from last year.
  • As of FY2024, Keros Therapeutics' Revenue stood at $3.5 million, which was up 2,250.99% from $151,000 recorded in FY2023.
  • In the past 5 years, Keros Therapeutics' Revenue registered a high of $18.0 million during FY2021, and its lowest value of -$6,000 during FY2020.
  • Its 3-year average for Revenue is $1.2 million, with a median of $151,000 in 2023.
  • Per our database at Business Quant, Keros Therapeutics' Revenue slumped by 100.06% in 2020 and then surged by 300,100.00% in 2021.
  • Keros Therapeutics' Revenue (Yearly) stood at -$6,000 in 2020, then skyrocketed by 300,100.00% to $18.0 million in 2021, then slumped by 100.01% to -$1,000 in 2022, then surged by 15,200.00% to $151,000 in 2023, then skyrocketed by 2,250.99% to $3.5 million in 2024.